Viktor Komlósi

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer

Viktor Komlósi, Erika Hitre, Éva Pap et al. · BMC Cancer · 2010 · 48 citations · Full text

Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

Arnon P. Kater, Önder Arslan, Fatih Demırkan et al. · The Lancet Oncology · 2024 · 30 citations · Full text

Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.

Judit Müller, Judit Kralovánszky, Vilmos Adleff et al. · PubMed · 2009 · 27 citations

Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab

Barna Budai, Viktor Komlósi, Vilmos Adleff et al. · Pharmacogenetics and Genomics · 2011 · 22 citations

Shmt1 1420, Medicine, Immunology +15

Enhancement of 5-Fluorouracil Efficacy on High COX-2 Expressing HCA-7 Cells by Low Dose Indomethacin and NS-398 but not on Low COX-2 Expressing HT-29 Cells

Andrea Réti, Gábor Barna, Éva Pap et al. · Pathology & Oncology Research · 2008 · 16 citations

Inflammation, Anti-inflammatory, Oncology +8